Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Am J Hematol ; 72(4): 234-42, 2003 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-12666133

RESUMO

Localization of plasmin activity on leukocyte surfaces plays a critical role in fibrinolysis as well as in pathological and physiological processes in which cells must degrade the extracellular matrix in order to migrate. The binding of plasminogen to leukocytic cell lines induces a 30- to 80-fold increase in the rate of plasminogen activation by tissue-type (tPA) and urokinase-type (uPA) plasminogen activators. In the present study we have examined the role of alpha-enolase in plasminogen activation on the cell surface. We produced and characterized a monoclonal antibody (MAb) 11G1 against purified alpha-enolase, which abrogated about 90% of cell-dependent plasminogen activation by either uPA or tPA on leukocytoid cell lines of different lineages: B-lymphocytic, T-lymphocytic, granulocytic, and monocytic cells. In addition, MAb 11G1 also blocked enhancement of plasmin formation by peripheral blood neutrophils and monocytes. In contrast, MAb 11G1 did not affect plasmin generation in the presence of fibrin, indicating that this antibody did not interact with fibrinolytic components in the absence of cells. These data suggest that, although leukocytic cells display several molecules that bind plasminogen, alpha-enolase is responsible for the majority of the promotion of plasminogen activation on the surfaces of leukocytic cells.


Assuntos
Anticorpos Monoclonais/farmacologia , Fibrinolisina/biossíntese , Proteínas de Neoplasias/antagonistas & inibidores , Fosfopiruvato Hidratase/antagonistas & inibidores , Plasminogênio/metabolismo , Adenocarcinoma/enzimologia , Adenocarcinoma/patologia , Anticorpos Monoclonais/efeitos dos fármacos , Linfócitos B/patologia , Células Sanguíneas/efeitos dos fármacos , Células Sanguíneas/metabolismo , Neoplasias da Mama/enzimologia , Neoplasias da Mama/patologia , Carboxipeptidase B , Carboxipeptidases/farmacologia , Depressão Química , Feminino , Fibrina/metabolismo , Fibrinogênio/metabolismo , Fibrinólise/efeitos dos fármacos , Humanos , Leucócitos/enzimologia , Invasividade Neoplásica , Proteínas de Neoplasias/imunologia , Fragmentos de Peptídeos/metabolismo , Fosfopiruvato Hidratase/imunologia , Ligação Proteica , Frações Subcelulares/efeitos dos fármacos , Trombina/metabolismo , Ativador de Plasminogênio Tecidual/metabolismo , Células Tumorais Cultivadas/efeitos dos fármacos , Células Tumorais Cultivadas/enzimologia , Ativador de Plasminogênio Tipo Uroquinase/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...